Eiger BioPharmaceuticals(EIGR) - 2022 Q2 - Earnings Call Transcript
Eiger BioPharmaceuticalsEiger BioPharmaceuticals(US:EIGR)2022-08-07 00:23
Financials

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Sarah Mathieson - SVP, Corporate Affairs David Cory - President & CEO Ingrid Choong - SVP-Clinical Development Eldon Mayer - Chief Commercial Officer Sriram Ryali - CFO Colleen Craig - VP-Metabolic Diseases Conference Call Participants Maurice Raycroft - Jefferies Robert Hazlett - BTIG Michael Higgins - Ladenburg Thalmann Operator [Starts Abruptly] and business update conference call. ...